Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.69%)
As of: Sep 10, 2026 · 2:25 PM EDT

Celularity (CELU) Interest Expenses (2020 - 2025)

Celularity's (CELU) quarterly Interest Expenses came in at $897000.0 in Q4 2025, down 50.5% year-over-year from $1.8 million in Q4 2024, and down 39.27% quarter-over-quarter from $1.5 million in Q3 2025.

Analysis

Celularity (CELU) Interest Expenses (2020 - 2025) Analysis & Trends

Celularity (CELU) has reported Interest Expenses for 5 consecutive years, with $897000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Interest Expenses fell 50.5% year-over-year to $897000.0 in Q4 2025; TTM through Dec 2025 was $6.8 million, a 7.82% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 7.82% from the prior year.
  • Interest Expenses was $897000.0 for Q4 2025 at Celularity, down from $1.5 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.4 million in Q1 2025 and troughed at $277000.0 in Q1 2023.
  • A 4-year average of $1.2 million and a median of $1.0 million in 2023 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses soared 314.44% in 2024 and tumbled 50.5% in 2025, its largest moves.
  • Over 4 years, Interest Expenses stood at $759000.0 in 2021, then slipped by 12.65% to $663000.0 in 2023, then jumped by 173.3% to $1.8 million in 2024, then tumbled by 50.5% to $897000.0 in 2025.
  • The last three Interest Expenses figures came in at $897000.0 (Q4 2025), $1.5 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Krystal Biotech 10.22 Bn 9.38 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - -
3 Iovance Biotherapeutics 3.64 Bn 3.34 Bn 55.72 Mn 4.00 Bn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -5.80 Mn
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn 14.37 Mn
6 Beam Therapeutics 2.52 Bn 2.52 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 2.95 Mn
8 Sarepta Therapeutics 2.15 Bn 1.35 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 160,000.00
10 Celularity 36.61 Mn 30.43 Mn -3.27 Mn 897,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 897,000.00
Sep 30, 2025 1.48 Mn
Jun 30, 2025 1.94 Mn
Mar 31, 2025 2.44 Mn
Dec 31, 2024 1.81 Mn
Sep 30, 2024 1.75 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 1.15 Mn
Dec 31, 2023 663,000.00
Sep 30, 2023 971,000.00
Jun 30, 2023 1.10 Mn
Mar 31, 2023 277,000.00
Dec 31, 2021 759,000.00
Sep 30, 2021 843,000.00
Jun 30, 2021 817,000.00
Mar 31, 2021 752,000.00
Dec 31, 2020 724,000.00
Sep 30, 2020 706,000.00